Korro Bio is trading 5.17% down at $11.19, with no verified company-specific explanation identified for the September 18 decline. - The stock fell from its September 17 close of $11.80. - The latest confirmed disclosure was a September 11 inducement grant involving 5,000 stock options. - The decline comes despite biotechnology sector strength; no clear broader-market catalyst matches the move, so delayed company news should be rechecked.